Marlowe CK - Search Results

1

Peptoids: a modular approach to drug discovery.

Simon RJ, Kania RS, Zuckermann RN, Huebner VD, Jewell DA, Banville S, Ng S, Wang L, Rosenberg S, Marlowe CK, et al. Simon RJ, et al. Among authors: marlowe ck. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9367-71. doi: 10.1073/pnas.89.20.9367. Proc Natl Acad Sci U S A. 1992. PMID: 1409642 Free PMC article.

2

Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality.

Mullenbach GT, Chiu CY, Gyenes A, Blaney J, Rosenberg S, Marlowe CK, Brown S, Stratton-Thomas J, Montelione GT, George-Nascimento C, Stauber G. Mullenbach GT, et al. Among authors: marlowe ck. Protein Eng. 1998 Jun;11(6):473-80. doi: 10.1093/protein/11.6.473. Protein Eng. 1998. PMID: 9725626

3

Solid phase organic synthesis (SPOS): a novel route to diketopiperazines and diketomorpholines.

Scott BO, Siegmund AC, Marlowe CK, Pei Y, Spear KL. Scott BO, et al. Among authors: marlowe ck. Mol Divers. 1996 Feb;1(2):125-34. doi: 10.1007/BF01721328. Mol Divers. 1996. PMID: 9237202

4

Design, synthesis and structure-activity relationship of a series of arginine aldehyde factor Xa inhibitors. Part 1: structures based on the (D)-Arg-Gly-Arg tripeptide sequence.

Marlowe CK, Sinha U, Gunn AC, Scarborough RM. Marlowe CK, et al. Bioorg Med Chem Lett. 2000 Jan 3;10(1):13-6. doi: 10.1016/s0960-894x(99)00582-x. Bioorg Med Chem Lett. 2000. PMID: 10636232

5

Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding.

Levy D, Marlowe C, Kane-Maguire K, Bao M, Cherbavaz D, Tomlinson J, Sedlock D, Scarborough R. Levy D, et al. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3085-8. doi: 10.1016/s0960-894x(02)00653-4. Bioorg Med Chem Lett. 2002. PMID: 12372507

6

Discovery of transition state factor Xa inhibitors as potential anticoagulant agents.

Zhu BY, Huang W, Su T, Marlowe C, Sinha U, Hollenbach S, Scarborough RM. Zhu BY, et al. Curr Top Med Chem. 2001 Jun;1(2):101-19. doi: 10.2174/1568026013395425. Curr Top Med Chem. 2001. PMID: 11899247 Review.

7

Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.

Sinha U, Ku P, Malinowski J, Zhu BY, Scarborough RM, Marlowe CK, Wong PW, Lin PH, Hollenbach SJ. Sinha U, et al. Among authors: marlowe ck. Eur J Pharmacol. 2000 Apr 21;395(1):51-9. doi: 10.1016/s0014-2999(00)00219-3. Eur J Pharmacol. 2000. PMID: 10781674

8

Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors.

Su T, Wu Y, Doughan B, Kane-Maguire K, Marlowe CK, Kanter JP, Woolfrey J, Huang B, Wong P, Sinha U, Park G, Malinowski J, Hollenbach S, Scarborough RM, Zhu BY. Su T, et al. Among authors: marlowe ck. Bioorg Med Chem Lett. 2001 Sep 3;11(17):2279-82. doi: 10.1016/s0960-894x(01)00447-4. Bioorg Med Chem Lett. 2001. PMID: 11527714

9

Quantitative structure-activity relationships of the inhibition of Pneumocystis carinii dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(X-phenyl)-s-triazines.

Marlowe CK, Selassie CD, Santi DV. Marlowe CK, et al. J Med Chem. 1995 Mar 17;38(6):967-72. doi: 10.1021/jm00006a016. J Med Chem. 1995. PMID: 7699713

10

Rapid detection of mecA in methicillin resistant Staphylococcus aureus using cycling probe technology.

Cloney L, Marlowe C, Wong A, Chow R, Bryan R. Cloney L, et al. Mol Cell Probes. 1999 Jun;13(3):191-7. doi: 10.1006/mcpr.1999.0235. Mol Cell Probes. 1999. PMID: 10369744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters